Back to Results
First PageMeta Content
Pharmaceuticals policy / Drugs / Pharmacy / Clinical pharmacology / Pharmaceutical industry / Pharmacy benefit management / Medicare Part D / Prescription costs / Health care in the United States / Pharmacology / Pharmaceutical sciences / Health


OnPoint: Health Policy Brief A Bi-Monthly Publication by the Massachusetts Association of Health Plans Volume 1, November[removed]Content researched by Courtney Cunningham and edited by Eric Linzer
Add to Reading List

Document Date: 2014-11-19 10:13:54


Open Document

File Size: 332,00 KB

Share Result on Facebook

Company

Gilead Sciences Inc. / Express Scripts Inc. / Pew Charitable Trust / IMS Health / CVS Caremark Big Pharma / AMP / Bloomberg / /

Country

United States / United Kingdom / New Zealand / /

Currency

USD / /

Facility

IMS Institute / /

Holiday

Commonwealth Day / /

IndustryTerm

therapeutics for diabetes / pharmaceuticals / pharmaceutical drugs / pharmaceutical / challenges new technologies / hepatitis C treatment / /

MedicalCondition

hepatitis C. Harvoni / cancer / Abilify Schizophrenia / erectile dysfunction / costly Hepatitis C / Advair COPD / diabetes / Hepatitis C / multiple sclerosis / Sovaldi Lantus Diabetes / breakthrough hepatitis C / MS / respiratory disease / /

Organization

Alliance for a Just Society VOX / Massachusetts Association of Health Plans / federal government / Massachusetts Association of Health Plans Volume / National Science Foundation / IMS Institute / U.S. government / FDA / IMS Institute for Healthcare Informatics Health / IMS Institute for Healthcare Informatics / Health Policy Commission / /

Person

Courtney Cunningham / /

Product

Humira / Copaxone / Harvoni / Lantus / Abilify / /

ProvinceOrState

Massachusetts / /

PublishedMedium

Businessweek / British Medical Journal / /

Technology

genotype / /

SocialTag